Detection of Intestinal Protozoa in Korean Patients Using BD MAX Enteric Parasite Panel and Seegene Allplex Gastrointestinal Parasite Assay
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Intestinal protozoan infection is one of the main causes of gastrointestinal diseases. Protozoa are usually detected by direct smear microscopy, concentration techniques, or special stains; however, these techniques are labor-intensive and require well-trained technicians. Therefore, molecular techniques involving polymerase chain reaction (PCR) have been developed to satisfy the need for unbiased and rapid analytical methods with high sensitivity and specificity. In this study, the BD MAXTM Enteric Parasite Panel (EPP) (Becton, Dickinson and Company, USA), designed to detect Cryptosporidium parvum and/or hominis, Giardia lamblia, and Entamoeba histolytica, and the AllplexTM Gastrointestinal Parasite Assays (AGPA) (Seegene Inc., Korea), designed to detect Cryptosporidium species, G. lamblia, E. histolytica, Blastocystis hominis, Dientamoeba fragilis, and Cyclospora cayetanensis were compared to determine whether any of these assays could become a useful tool for detecting intestinal protozoan infections in Korea. Methods: We investigated 295 fecal samples using EPP and AGPA. Then we confirmed the positive results with the conventional and nested PCR. Consistent detection by conventional PCR, nested PCR, and one of the multiplex panels was considered “true positive.”Results: Out of 295 samples, 17 were true positives for B. hominis and 2 were true positives for E. histolytica. EPP detected parasites in only two samples owing to its design; however, its true positive detection rate was 100% (2/2). AGPA detected parasites in 24 samples with 79.2% (19/24) true positives. Conclusions: The incidence of protozoan, especially B. hominis, infection may be more prevalent than expected. AGPA could be an effective tool for screening protozoan infections.
Abstract
Background: Intestinal protozoan infection is one of the main causes of gastrointestinal diseases. Protozoa are usually detected by direct smear microscopy, concentration techniques, or special stains; however, these techniques are labor-intensive and require well-trained technicians. Therefore, molecular techniques involving polymerase chain reaction (PCR) have been developed to satisfy the need for unbiased and rapid analytical methods with high sensitivity and specificity. In this study, the BD MAXTM Enteric Parasite Panel (EPP) (Becton, Dickinson and Company, USA), designed to detect Cryptosporidium parvum and/or hominis, Giardia lamblia, and Entamoeba histolytica, and the AllplexTM Gastrointestinal Parasite Assays (AGPA) (Seegene Inc., Korea), designed to detect Cryptosporidium species, G. lamblia, E. histolytica, Blastocystis hominis, Dientamoeba fragilis, and Cyclospora cayetanensis were compared to determine whether any of these assays could become a useful tool for detecting intestinal protozoan infections in Korea. Methods: We investigated 295 fecal samples using EPP and AGPA. Then we confirmed the positive results with the conventional and nested PCR. Consistent detection by conventional PCR, nested PCR, and one of the multiplex panels was considered “true positive.”Results: Out of 295 samples, 17 were true positives for B. hominis and 2 were true positives for E. histolytica. EPP detected parasites in only two samples owing to its design; however, its true positive detection rate was 100% (2/2). AGPA detected parasites in 24 samples with 79.2% (19/24) true positives. Conclusions: The incidence of protozoan, especially B. hominis, infection may be more prevalent than expected. AGPA could be an effective tool for screening protozoan infections.
참고문헌 (23)
- Fletcher SM, "Enteric protozoa in the developed world : a public health perspective", Clin Microbiol Rev, 25, pp.420~449 (2012)
- Won EJ, "Multiplex real-time PCR assay targeting eight parasites customized to the Korean population : Potential use for detection in diarrheal stool samples from gastroenteritis patients", PLoS One, 11, pp.e0166957~ (2016)
- Autier B, "Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa", Parasite, 25, pp.48~ (2018)
- Ocaña-Losada C, "Clinical and epidemiological characteristics of intestinal parasite infection by Blastocystis hominis", Rev Clin Esp, 218, pp.115~120 (2018)
- Mergani MH, "Detection of intestinal protozoa by using different methods", Dent Med Res, 2, pp.28~32 (2014)
- Ragavan AD, "Modified fields’ stain : ideal to differentiate Dientamoeba fragilis and Blastocystis sp", Parasitol Res, 114, pp.1163~1166 (2015)
- McHardy IH, "Detection of intestinal protozoa in the clinical laboratory", J Clin Microbiol, 52, pp.712~720 (2014)
- Van den Bossche D, "Comparison of four rapid diagnostic tests, ELISA, microscopy and PCR for the detection of Giardia lamblia, Cryptosporidium spp. and Entamoeba histolytica in feces", J Microbiol Methods, 110, pp.78~84 (2015)
- Laude A, "Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis, Cryptosporidium parvum", Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review, 2016, pp.22, 190.e1~190.e8
- Madison-Antenucci S, "Multicenter evaluation of BD Max Enteric Parasite Real-Time PCR Assay for detection of Giardia duodenalis, Cryptosporidium hominis, Cryptosporidium parvum, and Entamoeba histolytica", J Clin Microbiol, 54, pp.2681~2688 (2016)
- Verweij JJ, "Application of PCR-based methods for diagnosis of intestinal parasitic infections in the clinical laboratory", Parasitology, 141, pp.1863~1872 (2014)
- Adeyemo FE, "Methods for the detection of Cryptosporidium and Giardia : From microscopy to nucleic acid based tools in clinical and environmental regimes", Acta Trop, 184, pp.15~28 (2018)
- Parčina M, "Highly sensitive and specific detection of Giardia duodenalis, Entamoeba histolytica, and Cryptosporidium spp. in human stool samples by the BD MAX™ Enteric Parasite Panel", Parasitol Res, 117, pp.447~451 (2018)
- Perry MD, "Evaluation of the BD MAX Enteric Parasite Panel for the detection of Cryptosporidium parvum", hominis, Giardia duodenalis and Entamoeba histolytica, 2017, pp.66, 1118~1123
- Yoo J, "Comparative evaluation of Seegene Allplex Gastrointestinal, Luminex xTAG Gastrointestinal Pathogen Panel, and BD MAX Enteric Assays for detection of gastrointestinal pathogens in clinical stool specimens", Arch Pathol Lab Med, 143, pp.999~1005 (2019)
- Tan KS, "New insights on classification, identification, and clinical relevance of Blastocystis spp", Clin Microbiol Rev, 21, pp.639~665 (2008)
- Roberts T, "Subtype distribution of Blastocystis isolates from a variety of animals from New South Wales, Australia", Vet Parasitol, 196, pp.85~89 (2013)
- Clark CG, "Cryptic genetic variation in parasitic protozoa", J Med Microbiol, 49, pp.489~491 (2000)
- Stenzel DJ, "Blastocystis hominis revisited", Clin Microbiol Rev, 9, pp.563~584 (1996)
- Rajah Salim H, "Blastocystis in animal handlers", Parasitol Res, 85, pp.1032~1033 (1999)
- Kurt Ö, "Eradication of Blastocystis in humans : Really necessary for all", Parasitol Int, 65, pp.797~801 (2016)
- Craven LJ, "Extended screening costs associated with selecting donors for Fecal Microbiota Transplantation for treatment of metabolic syndrome-associated diseases", Open Forum Infect Dis, 4, pp.ofx243~ (2017)
- Zhang X, "In vitro culture of Blastocystis hominis in three liquid media and its usefulness in the diagnosis of blastocystosis", Int J Infect Dis, 16, pp.e23~e28 (2012)